Skip to main content

Want a detailed portfolio tracker?

Ionis Pharmaceuticals (IONS) P/E (2010 - 2026)

Ionis Pharmaceuticals (IONS) P/E from Mar 31, 2010 to Jun 3, 2026. The TTM Ionis Pharmaceuticals (IONS) P/E is -70.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ionis Pharmaceuticals (IONS)

YearP/EChange
2026-70.05+25.74%
2025-55.71+22.75%
2024-45.39+19.54%
2023-37.97-286.16%
202220.40+6.46%
202119.16-207.38%
2020-17.84-158.61%
201930.44+11.60%
201827.28-80.36%
2017138.92-542.77%
2016-31.37-93.39%
2015-474.76+155.87%
2014-185.55+144.59%
2013-75.86+371.95%
2012-16.07+76.24%
2011-9.12-44.34%
2010-16.39N/A

Comparison Ionis Pharmaceuticals (IONS) P/E with competitors

Ionis Pharmaceuticals (IONS) P/E is -70.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.10-100.15%
ENLVEnlivex Therapeutics Ltd0.15-100.21%
FGENFibroGen Inc0.24-100.34%
TRAWTraws Pharma Inc0.47-100.67%
FBIOFortress Biotech Inc0.71-101.01%
CHRSCoherus Biosciences Inc0.98-101.40%
ORMPOramed Pharmaceuticals Inc1.47-102.10%
AGENAgenus Inc2.05-102.92%
VIVSVivoSim Labs Inc2.54-103.62%
INVAInnoviva Inc3.19-104.55%
CRMDCorMedix Inc3.65-105.20%
ABEOAbeona Therapeutics Inc4.20-106.00%
VXRTVaxart Inc4.26-106.08%
CVACCureVac N.V.4.45-106.35%
SRPTSarepta Therapeutics Inc4.62-106.60%
GLPGGalapagos NV4.86-106.94%
RIGLRigel Pharmaceuticals4.92-107.02%
ZVRAZevra Therapeutics Inc4.97-107.10%
ABUSArbutus Biopharma Corp5.69-108.13%
CGENCompugen Ltd7.38-110.54%
AUPHAurinia Pharmaceuticals Inc9.25-113.21%
ACADAcadia Pharmaceuticals Inc9.59-113.69%
OMEROmeros Corporation9.88-114.11%
PLXProtalix BioTherapeutics Inc9.91-114.14%
SPROSpero Therapeutics Inc10.73-115.32%
ADMAAdma Biologics Inc11.33-116.17%
SVASinovac Biotech Ltd11.44-116.32%
TBPHTheravance Biopharma Inc11.78-116.81%
HRMYHarmony Biosciences Holdings Inc12.18-117.39%
TGTXTG Therapeutics Inc13.18-118.81%
INCYIncyte Corp13.38-119.10%
SABSSAB Biotherapeutics Inc14.06-120.07%
XOMAXOMA Corp14.95-121.33%
REGNRegeneron Pharmaceuticals Inc14.98-121.38%
PBYIPuma Biotechnology Inc15.05-121.48%
EXELExelixis Inc15.79-122.55%
NAGENiagen Bioscience Inc16.35-123.35%
CPRXCatalyst Pharmaceuticals Inc17.34-124.76%
MDXGMimedx Group Inc17.38-124.80%
ARGXArgen X SE23.07-132.93%
HALOHalozyme Therapeutics Inc23.20-133.12%
XOMAOXOMA Corp25.34-136.18%
VRTXVertex Pharmaceuticals Inc25.66-136.62%
XOMAPXOMA Corp25.67-136.64%
CTMXCytomX Therapeutics Inc25.70-136.68%
ASNDAscendis Pharma A/S26.35-137.62%
RPRXRoyalty Pharma plc - Class A27.50-139.25%
SLNOSoleno Therapeutics Inc29.02-141.42%
LGNDLigand Pharmaceuticals Inc - Class B30.19-143.09%
BMRNBiomarin Pharmaceutical Inc37.51-153.54%
APLSApellis Pharmaceuticals Inc39.02-155.70%
KRYSKrystal Biotech Inc39.70-156.67%
GMABGenmab40.20-157.39%
ONCBeiGene Ltd67.03-195.68%
TECHBio-Techne Corp68.59-197.92%
VCELVericel Corp80.63-215.09%
PHARPharming Group N.V.87.74-225.24%
ALNYAlnylam Pharmaceuticals Inc124.93-278.34%
TLXTelix Pharmaceuticals Ltd139.89-299.69%
CORTCorcept Therapeutics Inc158.39-326.09%